Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients.

Pesko, Bryan; Deng, Alexandra; Chan, Jeannie D; Neme, Santiago; Dhanireddy, Shireesha; Jain, Rupali

Pesko, Bryan; Deng, Alexandra; Chan, Jeannie D; Neme, Santiago; Dhanireddy, Shireesha; Jain, Rupali.

Afiliação

Pesko B; Department of Pharmacy, University of Washington Medicine, University of Washington Medical Center - Montlake, Seattle, Washington, USA.
Deng A; University of Washington School of Pharmacy, Seattle, Washington, USA.
Chan JD; University of Washington School of Pharmacy, Seattle, Washington, USA.
Neme S; University of Washington School of Pharmacy, Seattle, Washington, USA.
Dhanireddy S; Department of Pharmacy, University of Washington Medicine, Harborview Medical Center, Seattle, Washington, USA.
Jain R; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, USA.

Clin Infect Dis ; 75(11): 2049-2050, 2022 11 30.

Article em En | MEDLINE | ID: mdl-35869852

Assuntos

Inibidores da Protease de HIV; HIV-1; Humanos; Ritonavir/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: HIV-1 / Inibidores da Protease de HIV Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google